Plasma concentration of metformin and dexamethasone after administration through Osseogate

References

• Araki-Sasaki K, Katsuta O, Mano H, et al. (2016). The effects of oral and topical corticosteroid in rabbit corneas. BMC Ophthalmol 16:160
   PubMed Web of Science ®Google Scholar
• Beck JD, Offenbacher S. (2001). The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 6:9–15
   PubMedGoogle Scholar
• Cetin M, Sahin S. (2016). Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Deliv 23:2796–805
   PubMed Web of Science ®Google Scholar
• Chung SH, Kim HK, Shon WJ, et al. (2013). Peri-implant bone formations around (Ti,Zr)O(2)-coated zirconia implants with different surface roughness. J Clin Periodontol 40:404–11
   PubMed Web of Science ®Google Scholar
• Corti G, Capasso G, Maestrelli F, et al. (2007). Physical–chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin. J Pharm Biomed Anal 45:480–6
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche FM, et al. (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61–98
   PubMed Web of Science ®Google Scholar
• De Sousa FF, Ferraz C, Rodrigues LK, et al. (2014). Nanotechnology in dentistry: drug delivery systems for the control of biofilm-dependent oral diseases. Curr Drug Deliv 11:719–28
   PubMed Web of Science ®Google Scholar
• Defronzo RA, Goodman AM. (1995). Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333:541–9
   PubMed Web of Science ®Google Scholar
• Dilova V, Zlatarova V, Spirova N, et al. (2004). Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation. Boll Chim Farm 143:20–3
   PubMedGoogle Scholar
• Gitto CA, Plata WG, Schaaf NG. (1994). Evaluation of the peri-implant epithelial tissue of percutaneous implant abutments supporting maxillofacial prostheses. Int J Oral Maxillofac Implants 9:197–206
   PubMedGoogle Scholar
• Goiato MC, Pesqueira AA, Ramos Da Silva C, et al. (2009). Patient satisfaction with maxillofacial prosthesis. Literature review. J Plast Reconstr Aesthet Surg 62:175–80
   PubMed Web of Science ®Google Scholar
• Holpuch AS, Phelps MP, Desai KG, et al. (2012). Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemoprevention. Carcinogenesis 33:1098–105
   PubMed Web of Science ®Google Scholar
• Jain KK. (2008). Drug delivery system. 2nd ed. Totowa: Humana Press
   Google Scholar
• Jia R, Lu Y, Yang CW, et al. (2014). Effect of generation 4.0 polyamidoamine dendrimer on the mineralization of demineralized dentinal tubules in vitro. Arch Oral Biol 59:1085–93
   PubMed Web of Science ®Google Scholar
• Kalam MA. (2016). The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Int J Biol Macromol 89:559–68
   PubMed Web of Science ®Google Scholar
• Kaur G, Holtfreter B, Rathmann WG, et al. (2009). Association between type 1 and type 2 diabetes with periodontal disease and tooth loss. J Clin Periodontol 36:765–74
   PubMed Web of Science ®Google Scholar
• Kim K, Brar P, Jakubowski J, et al. (2009). The use of corticosteroids and nonsteroidal antiinflammatory medication for the management of pain and inflammation after third molar surgery: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:630–40
   PubMed Web of Science ®Google Scholar
• Kowall B, Holtfreter B, Völzke H, et al. (2015). Pre-diabetes and well-controlled diabetes are not associated with periodontal disease: the SHIP Trend Study. J Clin Periodontol 42:422–30
   PubMed Web of Science ®Google Scholar
• Loew D, Schuster O, Graul EH. (1986). Dose-dependent pharmacokinetics of dexamethasone. Eur J Clin Pharmacol 30:225–30
   PubMed Web of Science ®Google Scholar
• Losic D, Aw MS, Santos A, et al. (2015). Titania nanotube arrays for local drug delivery: recent advances and perspectives. Expert Opin Drug Deliv 12:103–27
   PubMed Web of Science ®Google Scholar
• Montgomery MT, Hogg JP, Roberts DL, et al. (1990). The use of glucocorticosteroids to lessen the inflammatory sequelae following third molar surgery. J Oral Maxillofac Surg 48:179–87
   PubMed Web of Science ®Google Scholar
• Park JH, Cha HS, Kim HK, et al. (2016). Dexamethasone delivery by an implant-mediated drug delivery system in the canine mandible. J Periodontol 87:700–5
   PubMed Web of Science ®Google Scholar
• Park YS, Chang MS, Lee SP. (2011). Three-dimensional topography of the gingival line of young adult maxillary teeth: curve averaging using reverse-engineering methods. Int J Oral Maxillofac Implants 26:1217–24
   PubMed Web of Science ®Google Scholar
• Park YS, Cho JY, Lee SJ, et al. (2014a). Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system. BioMed Res Int 2014:801358
   PubMed Web of Science ®Google Scholar
• Park YS, Lee SJ, Hwang CI. (2014b). New application of endosseous implants – implant mediated drug delivery system (IMDDS). J Kor Dent Assoc 52:550–7
   Google Scholar
• Pehlivan SB, Yavuz B, Calamak S, et al. (2015). Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application. J Pharm Sci 104:1709–20
   PubMed Web of Science ®Google Scholar
• Prieto E, Vispe E, Otin-Mallada S, et al. (2016). Determination of three corticosteroids in the biologic matrix of vitreous humor by HPLC–tandem mass spectrometry: method development and validation. Curr Eye Res 11:1–8. [Epub ahead of print]
   Web of Science ®Google Scholar
• Ramazanoglu M, Lutz R, Rusche P, et al. (2013). Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study. J Craniomaxillofac Surg 41:826–35
   PubMed Web of Science ®Google Scholar
• Renugalakshmi A, Vinothkumar TS, Kandaswamy D. (2011). Nanodrug delivery systems in dentistry: a review on current status and future perspectives. Curr Drug Deliv 8:586–94
   PubMed Web of Science ®Google Scholar
• Rhee SJ, Choi Y, Lee S, et al. (2016). Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects. Drug Des Dev Ther 10:2525–34
   PubMed Web of Science ®Google Scholar
• Sanders LM. (1990). Drug delivery systems and routes of administration of peptide and protein drugs. Eur J Drug Metab Pharmacokinet 15:95–102
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Howlett HC. (2008). Metformin therapy and clinical uses. Diab Vasc Dis Res 5:157–67
   PubMed Web of Science ®Google Scholar
• Silva De Melo NF, Campos EV, Goncalves CM, et al. (2014). Development of hydrophilic nanocarriers for the charged form of the local anesthetic articaine. Colloids Surf B Biointerfaces 121:66–73
   PubMed Web of Science ®Google Scholar
• Teeuw WJ, Gerdes VE, Loos BG. (2010). Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 33:421–7
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Sriwastawa B, et al. (2012). Drug delivery systems: an updated review. Int J Pharm Investig 2:2–11
   PubMedGoogle Scholar
• Umino M, Nagao M. (1993). Systemic diseases in elderly dental patients. Int Dent J 43:213–18
   PubMedGoogle Scholar
• Viollet B, Guigas B, Sanz Garcia N, et al. (2012). Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 122:253–70
   PubMed Web of Science ®Google Scholar
• Yao W, Xu P, Pang Z, et al. (2014). Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs. Int J Nanomedicine 9:3963–70
   PubMed Web of Science ®Google Scholar